This presentation will include both preclinical and small clinical studies with details on mechanism of action, safety and efficacy of a candidate drug that has the capability of alleviating dysregulation of the dopaminergic system and also, although less clearly documented, the serotonergic system, with potential usefulness in a variety of CNS disorders.